Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

583
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
583
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

66
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
66
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

218
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
218
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

101
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
101
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

69
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
69
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

160
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
160

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polymyxin B haemoadsorption in endotoxic septic shock (Tigris): a multicentre, open-label, Bayesian, randomised, controlled, phase 3 trial.

The Lancet. Respiratory medicine·2026
Same author

Infectious consequences of antimicrobial change from vancomycin-piperacillin/ tazobactam to vancomycin-cefepime in the prevention of AKI during orthotopic heart transplantation.

BMC infectious diseases·2026
Same author

Discrepancy in Estimating GFR for Melphalan Dosing in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplant: A Retrospective Analysis.

Kidney360·2026
Same author

Redefining the modern paradigm of vasopressor therapy for vasodilatory shock.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine·2026
Same author

Comparative Performance of Novel and Standard Urinary Kidney Biomarkers for Prediction of Persistent Severe Acute Kidney Injury and Long-Term Major Adverse Kidney Events.

American journal of nephrology·2026
Same author

Gas as medicine: the case for hydrogen gas as a therapeutic agent for critical illness.

Intensive care medicine experimental·2025

Related Experiment Video

Updated: Nov 6, 2025

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
07:59

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol

Published on: July 28, 2018

11.4K

The furosemide stress test: current use and future potential.

Blaithin A McMahon1, Lakhmir S Chawla2

  • 1Medical University of South Carolina, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA.

Renal Failure
|May 11, 2021
PubMed
Summary

Loop diuretics, like furosemide, are crucial for managing acute kidney injury (AKI) complications. The furosemide stress test now helps identify high-risk AKI patients and predict treatment needs.

Keywords:
Furosemideacute kidney injuryrenal replacement therapyrisk assessmentstress test

More Related Videos

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge
09:32

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge

Published on: January 20, 2023

3.7K
Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice
15:45

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice

Published on: February 10, 2013

18.5K

Related Experiment Videos

Last Updated: Nov 6, 2025

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
07:59

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol

Published on: July 28, 2018

11.4K
Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge
09:32

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge

Published on: January 20, 2023

3.7K
Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice
15:45

Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice

Published on: February 10, 2013

18.5K

Area of Science:

  • Nephrology
  • Pharmacology
  • Critical Care Medicine

Background:

  • Loop diuretics are essential for managing acute kidney injury (AKI), particularly volume overload and pulmonary edema.
  • Understanding loop diuretic renal pharmacology is key in AKI management.
  • Furosemide is a widely used loop diuretic with established roles in AKI care.

Purpose of the Study:

  • To review the renal pharmacology of furosemide in intact nephrons.
  • To discuss how AKI alters furosemide's response.
  • To highlight the emerging role of the furosemide stress test in AKI.

Main Methods:

  • Literature review summarizing furosemide pharmacology.
  • Analysis of studies on the furosemide stress test in AKI.
  • Discussion of clinical utility and future research directions.

Main Results:

  • Furosemide's natriuretic response is detailed, with considerations for AKI.
  • The furosemide stress test identifies AKI patients at risk of progression.
  • The test aids in predicting the need for and cessation of renal replacement therapy.

Conclusions:

  • The furosemide stress test offers novel insights into AKI management.
  • This test can stratify AKI patients for risk and treatment intensity.
  • Future studies should further explore furosemide's role in AKI.